{"id":42923,"date":"2014-07-08T08:11:57","date_gmt":"2014-07-08T12:11:57","guid":{"rendered":"http:\/\/www.hedgeco.net\/news\/?p=42923"},"modified":"2014-07-08T08:11:57","modified_gmt":"2014-07-08T12:11:57","slug":"ackmans-hedge-fund-offers-slate-of-directors-for-botox-maker-allergan","status":"publish","type":"post","link":"https:\/\/hedgeco.net\/news\/07\/2014\/ackmans-hedge-fund-offers-slate-of-directors-for-botox-maker-allergan.html","title":{"rendered":"Ackman\u2019s Hedge Fund Offers Slate of Directors for Botox Maker Allergan"},"content":{"rendered":"<p>DealBook &#8211; Pershing Square Capital Management unveiled a proposed slate of directors on Monday that it hopes to elect to the Allergan board.<\/p>\n<p>Pershing Square, which is working with Valeant Pharmaceuticals on a $53 billion hostile bid for the Botox maker Allergan, is still working to secure enough shareholder support to call a special meeting.<\/p>\n<p><a href=\"http:\/\/dealbook.nytimes.com\/2014\/07\/07\/pershing-square-offers-slate-of-directors-for-allergan\/\" target=\"_blank\"><strong>Read Complete Article<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DealBook &#8211; Pershing Square Capital Management unveiled a proposed slate of directors on Monday that it hopes to elect to the Allergan board. Pershing Square, which is working with Valeant Pharmaceuticals on a $53 billion hostile bid for the Botox [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-42923","post","type-post","status-publish","format-standard","hentry","category-syndicated"],"_links":{"self":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/42923","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/comments?post=42923"}],"version-history":[{"count":1,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/42923\/revisions"}],"predecessor-version":[{"id":42924,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/42923\/revisions\/42924"}],"wp:attachment":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/media?parent=42923"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/categories?post=42923"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/tags?post=42923"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}